Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2

Nature Communications

Volumn 6, Issue , 2015, Pages

  Liebl, Johanna ^a   Zhang, Siwei ^a   Moser, Markus ^b   Agalarov, Yan ^c,d   Demir, Cansaran Saygili ^c,d   Hager, Bianca ^a   Bibb, James A ^e   Adams, Ralf H ^f,g   Kiefer, Friedemann ^f   Miura, Naoyuki ^h   Petrova, Tatiana V ^c,i   Vollmar, Angelika M ^a   Zahler, Stefan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; TRANSCRIPTION FACTOR FOXC2; CDK5 PROTEIN, HUMAN; CDK5 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR;

BLOOD; ENZYME; GENE EXPRESSION; MOLECULAR ANALYSIS; MORPHOGENESIS;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; ELECTROPHORETIC MOBILITY; EMBRYO; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; MOUSE; MOUSE EMBRYO; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; HUMAN; KNOCKOUT MOUSE; MECHANICAL STRESS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CYCLIN-DEPENDENT KINASE 5; ENDOTHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; STRESS, MECHANICAL;

EID: 84931274891     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8274     Document Type: Article

References (45)

1. Tammela, T. & Alitalo, K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140, 460-476 (2010).
2. Yang, Y. et al. Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos. Blood 120, 2340-2348 (2012).
3. Hagerling, R. et al. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J. 32, 629-644 (2013).
4. Srinivasan, R. S. & Oliver, G. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes Dev. 25, 2187-2197 (2011).
5. Schulte-Merker, S., Sabine, A. & Petrova, T. V. Lymphatic vascular morphogenesis in development, physiology, and disease. J. Cell Biol. 193, 607-618 (2011).
6. Makinen, T. et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19, 397-410 (2005).
7. Bazigou, E. et al. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev. Cell 17, 175-186 (2009).
8. Jurisic, G. et al. An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circ. Res. 111, 426-436 (2012).
9. Bouvree, K. et al. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ. Res. 111, 437-445 (2012).
10. Petrova, T. V. et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10, 974-981 (2004).
11. Dhavan, R. & Tsai, L. H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749-759 (2001).
12. Liebl, J., Furst, R., Vollmar, A. M. & Zahler, S. Twice switched at birth: cell cycle-independent roles of the 'neuron-specific' cyclin-dependent kinase 5 (Cdk5) in non-neuronal cells. Cell Signal. 23, 1698-1707 (2011).
13. Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483-486 (2010).
14. Tang, Y., Harrington, A., Yang, X., Friesel, R. E. & Liaw, L. The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells. Genesis 48, 563-567 (2010).
15. Pareek, T. K. et al. Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 207, 2507-2519 (2010).
16. Chen, F., Wang, Q., Wang, X. & Studzinski, G. P. Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation. Cancer Res. 64, 5425-5433 (2004).
17. Studzinski, G. P. & Harrison, J. S. The neuronal cyclin-dependent kinase 5 activator p35Nck5a and Cdk5 activity in monocytic cells. Leuk. Lymphoma 44, 235-240 (2003).
18. Chen, F. & Studzinski, G. P. Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood 97, 3763-3767 (2001).
19. Liebl, J. et al. Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis. J. Biol. Chem. 285, 35932-35943 (2010).
20. Liebl, J. et al. Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases. Angiogenesis 14, 281-291 (2011).
21. Weitensteiner, S. B. et al. Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitors. PLoS ONE 8, e54607 (2013).
22. Ganguly, A. & Shields, C. L. Differential gene expression profile of retinoblastoma compared to normal retina. Mol. Vis. 16, 1292-1303 (2010).
23. Coxam, B. et al. Pkd1 regulates lymphatic vascular morphogenesis during development. Cell Rep. 7, 623-633 (2014).
24. Outeda, P. et al. Polycystin signaling is required for directed endothelial cell migration and lymphatic development. Cell Rep. 7, 634-644 (2014).
25. Hess, P. R. et al. Platelets mediate lymphovenous hemostasis to maintain bloodlymphatic separation throughout life. J. Clin. Invest. 124, 273-284 (2014).
26. Turner, C. J., Badu-Nkansah, K., Crowley, D., van der Flier, A. & Hynes, R. O. Integrin-alpha5beta1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation. Dev. Biol. 392, 381-392 (2014).
27. Bertozzi, C. C. et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116, 661-670 (2010).
28. Uhrin, P. et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 115, 3997-4005 (2010).
29. Fu, J. et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Invest. 118, 3725-3737 (2008).
30. Wei, G. et al. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 114, 1123-1130 (2009).
31. Ivanov, K. I. et al. Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells. Mol. Cell Biol. 33, 3749-3761 (2013).
32. Kriederman, B. M. et al. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum. Mol. Genet. 12, 1179-1185 (2003).
33. Fang, J. et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67, 1382-1388 (2000).
34. Finegold, D. N. et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum. Mol. Genet. 10, 1185-1189 (2001).
35. Iida, K. et al. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124, 4627-4638 (1997).
36. Kume, T., Jiang, H., Topczewska, J. M. & Hogan, B. L. The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis. Genes Dev. 15, 2470-2482 (2001).
37. Sabine, A. et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev. Cell 22, 430-445 (2012).
38. Kanady, J. D., Dellinger, M. T., Munger, S. J., Witte, M. H. & Simon, A. M. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev. Biol. 354, 253-266 (2011).
39. Norrmen, C. et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185, 439-457 (2009).
40. Hawasli, A. H. et al. Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat. Neurosci. 10, 880-886 (2007).
41. Betz, U. A., Vosshenrich, C. A., Rajewsky, K. & Muller, W. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination. Curr. Biol. 6, 1307-1316 (1996).
42. Kazenwadel, J., Secker, G. A., Betterman, K. L. & Harvey, N. L. In vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesis. PLoS ONE 7, e40497 (2012).
43. Kerjaschki, D. et al. Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J. Clin. Invest. 121, 2000-2012 (2011).
44. Schoppmann, S. F. et al. Telomerase-immortalized lymphatic and blood vessel endothelial cells are functionally stable and retain their lineage specificity. Microcirculation 11, 261-269 (2004).
45. Furst, R. et al. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ. Res. 96, 43-53 (2005).